Search Within

Kevin Charles Miller

Formats
  1. Meeting Abstract (7)
  2. Review (2)
  3. Editorial (1)
Groups
  1. Hematology-Oncology Fellows (10)
  2. Hematologic Malignancies, Division of (9)
  3. Center for Hematologic Malignancies (8)
  4. Clinical Pharmacy Specialists (8)
  5. Department of Medicine (8)
  6. Hematologic Malignancies Research (8)

More Groups

People
  1. Alexander Lesokhin (8)
  2. Carlyn Rose Tan (8)
  3. Hamza Hashmi (8)
  4. Issam Hamadeh (8)
  5. Sridevi Rajeeve (8)
  6. David Chung (7)

More People

Years
  1. 2025 (2)
  2. 2024 (8)
Publications
  1. Blood (4)
  2. Clinical Lymphoma, Myeloma and Leukemia (4)
  3. Cancer Management and Research (1)
  4. Frontiers in Oncology (1)
Publishers
  1. American Society of Hematology (4)
  2. Elsevier Inc. (4)
  3. Dove Medical Press Ltd (1)
  4. Frontiers Media S.A. (1)

Results (10)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Perspectives on talquetamab and its utility in the treatment of multiple myeloma: Safety, efficacy and place in therapy
    Review

    Miller, K. C.; Hamadeh, I.; Tan, C. R.
    Cancer Management and Research (2025)

    Fulltext@MSK | Save
  • Recycling is “bad to the bone” in patients with myeloma
    Editorial

    Miller, K. C.; Lesokhin, A. M.
    Blood (2025)

    Fulltext@MSK | Save
  • Real-world safety and early efficacy of talquetamab in patients with heavily-pretreated relapsed/refractory multiple myeloma
    Meeting Abstract

    Costa, B. A.; Tan, C. R.; Shekarkhand, T.; Firestone, R. S.; Jurgens, E. M.; Miller, K.; Lesokhin, A. M.; Shah, G. L.; Korde, N.; Rajeeve, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Infectious complications during treatment with commercial CAR T-cell therapy and bispecific antibodies for relapsed/refractory multiple myeloma
    Meeting Abstract

    Jurgens, E. M.; Shekarkhand, T.; Farzana, T.; Rueda, C.; Nemirovsky, D.; Derkach, A.; Firestone, R. S.; Nishimura, N.; Miller, K.; Costa, B. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Frailty and outcomes after bispecific T-cell engager therapy for patients with relapsed/refractory multiple myeloma
    Meeting Abstract

    Adegbite, B. O.; Tan, C. R.; Shekarkhand, T.; Firestone, R. S.; Jurgens, E. M.; Miller, K.; Lesokhin, A. M.; Shah, G. L.; Korde, N.; Rajeeve, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Impact of granulocyte colony-stimulating factor exposure on cytokine release syndrome during bispecific antibody initiation in relapsed/refractory multiple myeloma
    Meeting Abstract

    Wang, A.; Shekarkhand, T.; Derkach, A.; Nemirovsky, D.; Tan, C.; Hamadeh, I.; Firestone, R.; Jurgens, E.; Miller, K.; Korde, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • CMV reactivation during treatment with bispecific antibodies for relapsed/refractory multiple myeloma
    Meeting Abstract

    Jurgens, E.; Shekarkhand, T.; Rueda, C.; Nemirovsky, D.; Derkach, A.; Firestone, R.; Miller, K.; Costa, B.; Rajeeve, S.; Lesokhin, A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed/refractory multiple myeloma
    Meeting Abstract

    Costa, B.; Rajeeve, S.; Jurgens, E.; Nishimura, N.; Farzana, T.; Firestone, R.; Miller, K.; Lesokhin, A.; Shah, G.; Korde, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Real-world safety and early efficacy of talquetamab in patients with heavily-pretreated relapsed/refractory multiple myeloma
    Meeting Abstract

    Costa, B.; Tan, C.; Shekarkhand, T.; Firestone, R.; Jurgens, E.; Miller, K.; Lesokhin, A.; Shah, G.; Korde, N.; Rajeeve, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Beyond BCMA: The next wave of CAR T cell therapy in multiple myeloma
    Review

    Miller, K.; Hashmi, H.; Rajeeve, S.
    Frontiers in Oncology (2024)

    Fulltext@MSK | Save